Powassan Virus Cases Hit Record High as US Faces Growing Tick Threat
A rare and potentially fatal tick-borne virus is spreading across the United States at unprecedented levels, with federal data showing a tenfold increase in cases over the past decade and no vaccine or specific treatment available to stop it.
According to the Centers for Disease Control and Prevention, 76 Americans were diagnosed with Powassan virus in 2025 — the highest annual total ever recorded, compared to a historical average of just 7 to 8 diagnoses per year. As of June 30, 2026, the CDC has already reported 15 cases this year across five states, with additional infections confirmed in Maine and Rhode Island in late June.
What Makes Powassan Uniquely Dangerous
First discovered in 1958 in Powassan, Ontario, after the death of 4-year-old Lincoln Byers, the virus has long been considered a medical rarity. But public health experts warn that its transmission speed makes it fundamentally different from more common tick-borne illnesses.
“One of the most dangerous aspects is its rapid transmission,” Dr. Jorge P. Parada, medical advisor at the National Pest Management Association in Chicago, told Fox News Digital. “Powassan can be transmitted in as little as 15 minutes after the infected tick bites, while Lyme disease usually requires a 36- to 48-hour attachment time for transmission.”
This rapid transmission window means that standard prevention advice — checking for ticks after outdoor activity — offers far less protection against Powassan than against Lyme disease, since the virus can enter the bloodstream before a tick is noticed or removed.
A Rising Toll
The surge in cases follows a clear upward trajectory. CDC data shows that from 2004 to 2025, the agency recorded 476 total human disease cases and 63 deaths from Powassan virus. Annual cases remained in the single digits through the early 2010s before beginning a steady climb: 7 cases in 2015, 22 in 2016, 34 in 2017, and 43 in 2019. After a temporary dip during the pandemic years, cases resumed their rise, reaching 60 in 2024 and the record 76 in 2025.
So far in 2026, the CDC has confirmed cases in Massachusetts (5), New York (1), and Wisconsin (1) as of June 16. Since then, the Maine CDC confirmed a case in a Penobscot County resident on June 23 — the state’s first of the year — and Rhode Island reported a case in a Providence County man in his 60s who was hospitalized and is recovering.
Severe Outcomes and No Treatment
Approximately 10 to 15 percent of severe Powassan cases — those involving neuroinvasive disease — are fatal, according to the CDC. About half of survivors experience long-term neurological problems, including memory loss, difficulty walking, speaking, or eating.
The virus carries an incubation period of one to four weeks before symptoms manifest. Initial signs include fever, headache, vomiting, and weakness, though some infected individuals remain asymptomatic. In severe cases, the virus can progress to encephalitis (brain inflammation) or meningitis, with symptoms including confusion, loss of coordination, difficulty speaking, and seizures.
Dr. Saravanan Thangamani, professor of microbiology and immunology at SUNY Upstate Medical University, told Infectious Disease Advisor that while Powassan remains rare, “it actually has a high human health consequence.”
There are currently no specific antiviral medications or vaccines for Powassan virus. Clinical care is limited to supportive therapy — intravenous fluids, respiratory support, and steroids to reduce brain swelling.
Why Cases Are Rising
Experts point to several factors driving the increase, with climate change at the forefront. Warmer temperatures have lengthened tick season, pushing activity into March and November. Milder winters may be boosting populations of deer and rodents that ticks feed on, while tick habitats are expanding northward into previously unaffected regions.
Improved diagnostic capabilities and greater clinician awareness are also likely detecting more cases that might previously have gone unidentified. The CDC acknowledges that under-reporting remains a limitation of all surveillance systems, meaning the true number of infections is probably higher than reported.
Prevention Is the Only Defense
With no vaccine available, prevention relies entirely on avoiding tick bites. Health officials recommend using EPA-registered insect repellents containing DEET or picaridin, treating clothing with permethrin, wearing long sleeves and pants in wooded or grassy areas, and performing thorough tick checks after outdoor activity.
Tumbling dry clothing on high heat for 10 minutes can kill any ticks that may have hitched a ride. If a tick is found attached, it should be removed with tweezers near the head, and individuals should monitor for fever for 30 days.
What’s Next
As tick season peaks through the late summer and fall, public health officials expect cases to continue rising. The CDC will update its surveillance data every one to two weeks through December. State health departments in the Northeast and Upper Midwest — the most affected regions — are issuing advisories urging clinicians to consider Powassan testing in patients with unexplained fever, meningitis, or encephalitis.
The absence of a vaccine or specific treatment highlights a critical gap in preparedness for emerging vector-borne diseases — one that researchers say will only grow more urgent as climate change continues to expand the range and season of tick activity across the United States.